Changes in Myocardial Light Chain Amyloid Burden After Plasma Cell Therapy

Key Points

• Reduction in myocardial light chain amyloid burden indicates therapy effectiveness, with implications for heart function.
• A significant decrease in amyloid burden was observed in patients following plasma cell therapy over six months.
• The therapy assessment involved measuring amyloid levels using imaging techniques and biomarkers.
• These findings support potential improvements in cardiac health, but further studies are needed for broader validation.